SFWJ / Medcana Announces it is Canceling over 80 Million Shares
Medcana (OTC PINK:SFWJ) has announced the cancellation of 86,916,294 shares of its Common stock. The shares, which were issued several years ago and held in book entry by the transfer agent, will be fully canceled without any new shares being issued as replacement.
This strategic move is part of the company's efforts to reduce the share structure inherited from its shell merger. CEO José Gabriel Díaz described this as an 'excellent first step' while highlighting the company's progress in advancing operations in Colombia.
Medcana operates as a U.S.-based public company in the international medical cannabis sector, focusing on production, research, and global distribution of pharmaceutical-grade cannabis products through its Colombian operations and strategic partnerships.
Medcana (OTC PINK:SFWJ) ha annunciato la cancellazione di 86.916.294 azioni del suo stock comune. Le azioni, emesse diversi anni fa e detenute in forma di registrazione dal trasferimento agente, saranno completamente cancellate senza che vengano emesse nuove azioni in sostituzione.
Questa mossa strategica fa parte degli sforzi dell'azienda per ridurre la struttura azionaria ereditata dalla sua fusione con una shell. Il CEO José Gabriel Díaz ha descritto questo come un 'ottimo primo passo', sottolineando i progressi dell'azienda nel migliorare le operazioni in Colombia.
Medcana opera come una società pubblica con sede negli Stati Uniti nel settore internazionale della cannabis medica, concentrandosi sulla produzione, ricerca e distribuzione globale di prodotti a base di cannabis di grado farmaceutico attraverso le sue operazioni colombiane e partnership strategiche.
Medcana (OTC PINK:SFWJ) ha anunciado la cancelación de 86,916,294 acciones de su capital social. Las acciones, que fueron emitidas hace varios años y mantenidas en registro por el agente de transferencia, serán canceladas completamente sin que se emitan nuevas acciones como reemplazo.
Este movimiento estratégico es parte de los esfuerzos de la empresa para reducir la estructura accionaria heredada de su fusión con una shell. El CEO José Gabriel Díaz describió esto como un 'excelente primer paso', destacando el progreso de la empresa en la mejora de las operaciones en Colombia.
Medcana opera como una empresa pública con sede en EE. UU. en el sector internacional del cannabis medicinal, enfocándose en la producción, investigación y distribución global de productos de cannabis de grado farmacéutico a través de sus operaciones en Colombia y asociaciones estratégicas.
Medcana (OTC PINK:SFWJ)는 86,916,294주의 보통주를 취소한다고 발표했습니다. 이 주식은 몇 년 전에 발행되었으며, 이전 에이전트에 의해 장부에 기록된 상태로 유지되고 있으며, 새로운 주식이 대체로 발행되지 않고 완전히 취소됩니다.
이 전략적 결정은 회사가 셸 합병에서 물려받은 주식 구조를 줄이기 위한 노력의 일환입니다. CEO José Gabriel Díaz는 이를 '훌륭한 첫 걸음'으로 묘사하며, 콜롬비아에서의 운영 개선에 대한 회사의 진전을 강조했습니다.
Medcana는 미국에 본사를 둔 공개 회사로, 국제 의약용 대마초 분야에서 운영하며, 콜롬비아의 운영 및 전략적 파트너십을 통해 의약품 수준의 대마초 제품의 생산, 연구 및 글로벌 유통에 집중하고 있습니다.
Medcana (OTC PINK:SFWJ) a annoncé l'annulation de 86.916.294 actions de son capital social. Les actions, qui ont été émises il y a plusieurs années et conservées en tant qu'enregistrement par l'agent de transfert, seront complètement annulées sans qu'aucune nouvelle action ne soit émise en remplacement.
Ce mouvement stratégique fait partie des efforts de l'entreprise pour réduire la structure d'actions héritée de sa fusion avec une shell. Le PDG José Gabriel Díaz a décrit cela comme un 'excellent premier pas', tout en soulignant les progrès de l'entreprise dans l'avancement de ses opérations en Colombie.
Medcana opère en tant qu'entreprise publique basée aux États-Unis dans le secteur international du cannabis médical, en se concentrant sur la production, la recherche et la distribution mondiale de produits à base de cannabis de qualité pharmaceutique à travers ses opérations colombiennes et ses partenariats stratégiques.
Medcana (OTC PINK:SFWJ) hat die Stornierung von 86.916.294 Aktien ihrer Stammaktien angekündigt. Die Aktien, die vor mehreren Jahren ausgegeben und vom Übertragungsagenten in Buchform gehalten wurden, werden vollständig storniert, ohne dass neue Aktien als Ersatz ausgegeben werden.
Dieser strategische Schritt ist Teil der Bemühungen des Unternehmens, die von seiner Shell-Fusion geerbte Aktienstruktur zu reduzieren. CEO José Gabriel Díaz bezeichnete dies als 'ausgezeichneten ersten Schritt' und hob die Fortschritte des Unternehmens bei der Verbesserung der Abläufe in Kolumbien hervor.
Medcana agiert als ein in den USA ansässiges öffentliches Unternehmen im internationalen medizinischen Cannabis-Sektor und konzentriert sich auf die Produktion, Forschung und globale Verteilung von pharmazeutischen Cannabisprodukten durch seine kolumbianischen Betriebe und strategischen Partnerschaften.
- Cancellation of 86.9M shares reduces share dilution
- No new shares being issued as replacement
- Strategic move to strengthen share structure
- Existence of legacy shares that could have entered the system at any time
AUSTIN, TEXAS / ACCESS Newswire / April 10, 2025 / Software Effective Solutions Corp. (OTC PINK:SFWJ), doing business as Medcana, is canceling 86,916,294 million shares of its Common stock.
The shares were issued several years ago, and even though they have a legend on them, they could have entered the system at any time. This will be a full cancellation, and no new shares are being issued to replace them. The transfer agent holds the shares in book entry. The paperwork has been supplied by both the Company and the current shareholder to facilitate the cancellation.
The Company is working to significantly reduce the share structure it inherited when it merged into the shell.
José Gabriel Díaz, our CEO, stated, "This is an excellent first step, but we have more work to do. We are making tremendous strides in advancing our operations in Colombia, and a stronger share structure will help enhance our value for all shareholders."
About Medcana
Medcana is a U.S.-based public company operating in the international medical cannabis sector. Through its Colombian operations and strategic partnerships, Medcana is focused on the production, research, and global distribution of high-quality pharmaceutical-grade cannabis products.
For investor relations or media inquiries, please contact:
investors@medcana.com
www.medcana.com
Twitter: @MedcanaCo
SOURCE: Software Effective Solutions
View the original press release on ACCESS Newswire
FAQ
How many shares is SFWJ canceling in April 2025?
What is the purpose of SFWJ's share cancellation?
Will SFWJ issue new shares to replace the canceled ones?
What is Medcana's (SFWJ) main business focus?
